Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.

@article{GarciaTsao2006ModelFE,
  title={Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.},
  author={G Garcia-Tsao and Robert Gish and Jeffrey Punch},
  journal={Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  year={2006},
  volume={12 12 Suppl 3},
  pages={S108-9}
}
Hereditary hemorrhagic telangiectasia (HHT), also called Rendu-Osler-Weber syndrome, is a rare autosomal dominant disease characterized by arteriovenous malformations involving the skin, mucous membranes, lungs, brain, and gastrointestinal tract. The genetic origin of this disease appears to be a defect in transmembrane proteins that are components of the receptor complex for transforming growth factor(endoglin, activin receptor like-kinase 1). Hepatic involvement is frequent, but it is… CONTINUE READING